Neurocrine Biosciences Reports Second Quarter 2024 Financial Results and Raises 2024 INGREZZA Sales Guidance
Go back to Neurocrine Biosciences Reports Second Quarter 2024 Financial Results and Raises 2024 INGREZZA Sales Guidance| Neurocrine Biosciences, Inc. (NASDAQ: NBIX) | Delayed: 159.76 -2.95 (1.81%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $162.71 | 52 Week High | $58.46 | |||
| Open | $162.04 | 52 Week Low | $31.25 | |||
| Day High | $162.97 | P/E | N/A | |||
| Day Low | $159.44 | EPS | $-0.69 | |||
| Volume | 1,055,121 | |||||
